3',5'-Di-O-benzoyl-2'-deoxy-2',2'-difluorocytidine
CAS: 134790-39-9
Ref. 3D-ND08303
2g | 136,00 € | ||
5g | 192,00 € | ||
10g | 271,00 € | ||
25g | 406,00 € | ||
50g | 543,00 € |
Informação sobre produto
- 2',2'-Difluoro-3',5'-dibenzoyl-2'-deoxycytidineGemcitabine3',5'-Di-O-benzoyl-2'-deoxy-2',2'-difluoro-D-cytidine3',5'-Di-O-benzoyl -2',2'-difluoro-2'-deoxycytidine
- 2',2'-Difluoro-3',5'-dibenzoyl-2'-deoxycytidine
- 2',2'-Difluoro-3',5'-dibenzoyl-2'-deoxycytidine (beta isomer)
- 2'-deoxy-2',2'-difluoro-3',5'-bis-O-(phenylcarbonyl)cytidine
- 2,2-Difluoro-2-Deoxycytidine-3,5-Dibenzoate
- 3',5'-Di-O-benzoyl-2',2'-difluoro-2'-deoxy cytidine
- 3′,5′-Di-O-benzoyl-2′-deoxy-2′,2′-difluorocytidine
- Cytidine, 2′-deoxy-2′,2′-difluoro-, 3′,5′-dibenzoate
- T9
- T9:2’,2’-Difluoro-2’-deoxycytidine-3’,5’-dibenzoate
- Ver mais sinónimos
Folfirinox is a nucleoside analog that is structurally related to gemcitabine. It is metabolized by the enzyme equilibrative nucleoside transporter (ENT) to form 2'-deoxy-2',2'-difluorocytidine (DFD), which is incorporated into DNA by polymerase chain reaction. Folfirinox has been shown to have antitumor immunity and immunomodulatory effects in mice and humans, and it also has the potential to be used as a radiosensitizer for squamous cell carcinomas. Folfirinox has been found to be effective against pancreatic cancer cells in vitro and in vivo, with a median survival time of 36 days for mice treated with low doses of the drug.
Propriedades químicas
Consulta técnica sobre: 3D-ND08303 3',5'-Di-O-benzoyl-2'-deoxy-2',2'-difluorocytidine
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.